Breast cancer is the most common type of cancer in women and the second most fatal
cancer. Approximately 12.3% of women will be diagnosed with breast cancer at some point …

Gadolinium‐based contrast agents (GBCAs) are widely and routinely used to enhance the
diagnostic performance of magnetic resonance imaging and magnetic resonance …

Background Contrast‐enhanced magnetic resonance imaging (CE‐MRI) of the breast is
highly sensitive for breast cancer detection. Multichannel coils and 3T scanners can …

Dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) with gadolinium
constitutes one of the most promising protocols for boosting up the sensitivity in breast …

There are ongoing research efforts to develop accurate computer-aided diagnosis systems
for detecting benign and malignant breast masses. Studies are mainly focusing on imaging …

Objective To evaluate low-dose gadobenate dimeglumine-enhanced MRI for the differential
diagnosis of malignant renal tumors. Methods Sixty-two consecutive patients with unclear …

The present study aimed to evaluate one-sided increased vascularity in contrast-enhanced
breast MRIs in differential diagnosis of benign and malignant breast lesions. A total of 36 …

Gadolinium-based contrast agents (GBCAs) available for magnetic resonance imaging
(MRI) of the breast cause tissue signal changes that influence not only the diagnostic …

Purely morphological imaging modalities such as digital mammography and breast
ultrasound still represent the backbone of breast imaging. However, a sizable diagnostic …

AIM: We aimed to evaluate the effect of PET taken before surgery on the treatment protocol
in patients diagnosed with BC and whether PET resulted in changes in the disease stage …